Limb preservation surgery with extracorporeal irradiation in the management of malignant bone tumor: The oncological outcomes of 101 patients

Annals of Oncology

Volumn 24, Issue 10, 2013, Pages 2676-2680

  Hong, A M ^a,b   Millington, S ^a   Ahern, S ^c   McCowage, G ^d   Boyle, R ^a   Tattersall, M ^a,b   Haydu, L ^b   Stalley, P D ^a  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

^d CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Chondrosarcoma; Ewing's sarcoma; Extracorporeal; Osteosarcoma; Radiation; Sarcoma

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD EXTRACORPOREAL RADIATION; BONE CANCER; BONE GRAFT; BONE RESECTION; BONE TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CHILD; CHONDROSARCOMA; CONTROLLED STUDY; DOSE RESPONSE; EWING SARCOMA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; ORGAN PRESERVATION; OSTEOSARCOMA; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; WALKING;

CHONDROSARCOMA; EWING'S SARCOMA; EXTRACORPOREAL; OSTEOSARCOMA; RADIATION; SARCOMA;

ADOLESCENT; ADULT; AGED; BONE AND BONES; BONE NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHONDROSARCOMA; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; SARCOMA, EWING; SURVIVAL RATE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84884706745     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdt252     Document Type: Article

References (20)

1. Spira E, Lubin E. Extracorporeal irradiation of bone tumors. A preliminary report. Isr J Med Sci 1968; 4: 1015-1019.
2. Hong A, Stevens G, Stalley P et al. Extracorporeal irradiation for malignant bone tumors. Int J Radiat Oncol Biol Phys 2001; 50: 441-447.
3. Davidson AW, Hong A, McCarthy SW et al. En-bloc resection, extracorporeal irradiation, and re-implantation in limb salvage for bony malignancies. J Bone Joint Surg Br 2005; 87: 851-857.
4. Krieg AH, Davidson AW, Stalley PD. Intercalary femoral reconstruction with extracorporeal irradiated autogenous bone graft in limb-salvage surgery. J Bone Joint Surg Br 2007; 89: 366-371.
5. Krieg AH, Mani M, Speth BM et al. Extracorporeal irradiation for pelvic reconstruction in Ewing's sarcoma. J Bone Joint Surg Br 2009; 91: 395-400.
6. Schuck A, Ahrens S, Paulussen M et al. Local therapy in localized Ewing tumors: results of 1058 patients treated in the CESS 81, CESS 86, and EICESS 92 trials. Int J Radiat Oncol Biol Phys 2003; 55: 168-177.
7. Paulussen M, Ahrens S, Dunst J et al. Localized Ewing tumor of bone: final results of the cooperative Ewing's Sarcoma Study CESS 86. J Clin Oncol 2001; 19: 1818-1829.
8. Paulussen M, Craft AW, Lewis I et al. Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment-cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients. J Clin Oncol 2008; 26: 4385-4393.
9. Damron TA, Ward WG, Stewart A. Osteosarcoma, chondrosarcoma, and Ewing's sarcoma: National Cancer Data Base Report. Clin Orthop Relat Res 2007; 459: 40-47.
10. Ferrari S, Smeland S, Mercuri M et al. Neoadjuvant chemotherapy with high-dose ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005; 23: 8845-8852.
11. Smeland S, Bruland OS, Hjorth L et al. Results of the Scandinavian Sarcoma Group XIV protocol for classical osteosarcoma: 63 patients with a minimum followup of 4 years. Acta Orthop 2011; 82: 211-216.
12. Ferrari S, Ruggieri P, Cefalo G et al. Neoadjuvant chemotherapy with methotrexate, cisplatin, and doxorubicin with or without ifosfamide in nonmetastatic osteosarcoma of the extremity: an Italian sarcoma group trial ISG/OS-1. J Clin Oncol 2012; 30: 2112-2118.
13. Fiorenza F, Abudu A, Grimer RJ et al. Risk factors for survival and local control in chondrosarcoma of bone. J Bone Joint Surg Br 2002; 84: 93-99.
14. Alman BA, De Bari A, Krajbich JI. Massive allografts in the treatment of osteosarcoma and Ewing sarcoma in children and adolescents. J Bone Joint Surg Am 1995; 77: 54-64.
15. Frisoni T, Cevolani L, Giorgini A et al. Factors affecting outcome of massive intercalary bone allografts in the treatment of tumours of the femur. J Bone Joint Surg Br 2012; 94: 836-841.
16. Fox EJ, Hau MA, Gebhardt MC et al. Long-term follow up of proximal femoral allografts. Clin Orthop Relat Res 2002; 397: 106-113.
17. Donati D, Colangeli M, Colangeli S et al. Allograft-prosthetic composite in the proximal tibia after bone tumor resection. Clin Orthop Relat Res 2008; 466: 459-465.
18. Li X, Moretti VM, Ashana AO et al. Perioperative infection rate in patients with osteosarcomas treated with resection and prosthetic reconstruction. Clin Orthop Relat Res 2011; 469: 2889-2894.
19. Longhi A, Ferrari S, Tamburini A et al. Late effects of chemotherapy and radiotherapy in osteosarcoma and Ewing sarcoma patients: The Italian Sarcoma Group Experience (1983-2006). Cancer 2012; 118: 5050-5059.
20. Goitein M, Jermann M. The relative costs of proton and X-ray radiation therapy. Clin Oncol 2003; 15: S37-S50.